cefotaxime was found to be an effective antimicrobial in the treatment of 40 cancer patients with infections of the urinary or lower respiratory tracts , bacteremia , soft-tissue infections , and fever of undetermined origin .
C0007554
cefotaxime
C0149778
soft-tissue infections